Results 101 to 110 of about 1,722 (115)

Role of the sympathetic nervous system in cancer-associated cachexia and tumor progression in tumor-bearing BALB/c mice. [PDF]

open access: yesBMC Neurosci
Gutierrez-Leal I   +7 more
europepmc   +1 more source

Engineering Bacopa monnieri for improved bacoside content and its neurological evaluation. [PDF]

open access: yesAppl Microbiol Biotechnol
Jeena GS   +10 more
europepmc   +1 more source

Olfactory Dysfunction in a Novel Model of Prodromal Parkinson's Disease in Adult Zebrafish. [PDF]

open access: yesInt J Mol Sci
Vorhees NW   +8 more
europepmc   +1 more source

A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson's Disease. [PDF]

open access: yesCells
Spinaci A   +10 more
europepmc   +1 more source

Oxidopamine and oxidative stress: Recent advances in experimental physiology and pharmacology

open access: closedChemico-Biological Interactions, 2021
Oxidopamine (6-hydroxydopamine, 6-OHDA) is a toxin commonly used for the creation of experimental animal models of Parkinson's disease, attention-deficit hyperactivity disorder, and Lesch-Nyhan syndrome. Its exact mechanism of action is not completely understood, although there are many indications that it is related to the generation of reactive ...
Igor, Pantic   +4 more
openaire   +3 more sources

Gray level co-occurrence matrix algorithm as pattern recognition biosensor for oxidopamine-induced changes in lymphocyte chromatin architecture

open access: closedJournal of Theoretical Biology, 2016
We demonstrate that a proapoptotic chemical agent, oxidopamine, induces dose dependent changes in chromatin textural patterns which can be quantified using the Gray level co-occurrence matrix (GLCM) method. Peripheral blood (heparin-pretreated) samples were treated with oxidopamine (6-OHDA, 6-hydroxydopamine) to achieve effective concentrations of 100,
Igor, Pantic   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy